Back to Dulaglutide research

Comparative Efficacy and Safety of Tirzepatide Versus Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


dulaglutide tirzepatide gip agonist glp 1 agonist glp-1r dose mentioned safety data present
Source: pubmed:41975852 · Ingested Apr 14, 2026